Pharmacokinetic-guided Dosing of Emicizumab

Conditions: Hemophilia A With Inhibitor; Hemophilia A Without Inhibitor; Hemophilia A, Severe; Adolescent; Child; Adult Interventions: Other: Emicizumab - PK-guided dose reduction; Other: Emicizumab - Dosis continuation group; Other: Emicizumab - Dose adjustment group Sponsors: Kathelijn Fischer; Erasmus Medical Center; Amsterdam University Medical Center; Leiden University Medical Center; Radboud University Medical Center; Maastricht University Medical Center; University Medical Center Groningen; HagaZiekenhuis; Dutch Society of Haemophilia Patients Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials